Navigation Links
HIV Drug Tenofovir Safe During Pregnancy, Study Suggests

THURSDAY, May 3 (HealthDay News) -- The use of the anti-HIV drug tenofovir during pregnancy appears to be safe for infants, new research suggests.

In combination with other anti-HIV drugs, tenofovir (Viread) is the first line of treatment for adults with HIV, the virus that causes AIDS. These findings should reassure pregnant women who are taking tenofovir, the researchers said.

The study was conducted by the U.S. National Institutes of Health network because previous studies showed that laboratory animals exposed to tenofovir in the womb were smaller at birth than those that were not exposed to the drug.

The new study included 2,000 infants born to HIV-positive mothers between 2003 and 2010 in the United States. Infants born to mothers who took tenofovir during pregnancy did not weigh less at birth and did not have shorter length than those born to women who did not take the drug.

At 1 year of age, however, children born to mothers who took tenofovir during pregnancy were slightly shorter and had slightly smaller head circumference (an average of about 1 centimeter) than children whose mothers did not take the drug, the investigators found.

The researchers said further studies should be conducted to follow the children as they grow and develop in order to identify any potential long-term effects of taking tenofovir during pregnancy.

The study was released online April 26 in advance of publication in an upcoming print issue of the journal AIDS.

"This study produced reassuring information regarding the use of tenofovir," first author Dr. George Siberry, of the Pediatric, Adolescent and Maternal AIDS Branch of the U.S. National Institute of Child Health and Human Development, said in a National Institutes of Health news release.

"Although further research is needed ... our findings favor the use of tenofovir in pregnancy to ensure good outcomes in the mother and prevent transmission of HIV to the infant," Siberry added.

More information

The New Mexico AIDS Education and Training Center has more about HIV and pregnancy.

-- Robert Preidt

SOURCE: U.S. National Institute of Child Health and Human Development, news release, May 1, 2012

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Tenofovir gel dropped from HIV prevention trial in women because it was not effective
2. Major HIV prevention trial in women to drop oral tenofovir arm
3. Next steps for Tenofovir gel: CONRAD and TIA sign license agreement
4. Study comparing tenofovir gel and oral tablet finds gel provides more drug to tissue
5. Tenofovir gel provides high level of protection against HIV in rectal tissue
6. Promising HIV prevention microbicide tenofovir gel being tested for safety of rectal use
7. Heroin Addicts Have Higher Pain Sensitivity, Even During Treatment
8. Presidential Recognition Awards presented during the 2012 AIUM Annual Convention
9. Exercise improves quality of life during breast cancer treatment
10. Few young women with cancer take steps to preserve fertility during treatments
11. Use of anesthesia providers during GI procedures is growing, but may be unnecessary
Post Your Comments:
Related Image:
HIV Drug Tenofovir Safe During Pregnancy, Study Suggests
(Date:11/30/2015)... ... 01, 2015 , ... The Turks & Caicos Islands has enjoyed being in ... sites highlighting Caribbean destinations, has published five reasons to visit the Turks & Caicos. ... under chilly grey skies or worse, it's typically a balmy 80 degrees in the ...
(Date:11/30/2015)... MN (PRWEB) , ... December 01, 2015 , ... ... is the latest carrier to offer individual vision insurance plans on ... the unique ability to rate and review products, allowing consumers to compare, quote ...
(Date:11/30/2015)... ... November 30, 2015 , ... According to research by ... require dental technicians to be certified or obtain continuing education. To increase awareness ... In Your Mouth?” campaign to inform dentists that the technicians they trust could ...
(Date:11/30/2015)... ... November 30, 2015 , ... The world of hair ... and follicular unit extraction. These techniques and procedures have been in use for many ... hair loss. While Dr. Parsa Mohebi, M.D. has utilized many of these methods over ...
(Date:11/30/2015)... ... November 30, 2015 , ... During the ... campaign to raise funds for its research, education, support, and advocacy efforts. The ... annual funding. , The Mesothelioma Applied Research Foundation, which also goes by Meso ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , December 1, 2015 ... adds "Endometriosis - Pipeline Review, ... an overview on therapeutic pipeline of Endometriosis ... create effective counter strategies to gain competitive ... new targets and MOAs to produce first-in-class ...
(Date:11/30/2015)... 2015 ) ... Drugs Market 2015-2019" report to their offering. ... addition of the "Orphan Drugs Market 2015-2019" ... Research and Markets ( ) has announced ... 2015-2019" report to their offering. ...
(Date:11/30/2015)... , Nov. 30, 2015   Royal Philips ... Implant, the industry,s first MRI guided user interface and ... of patients with MR Conditional implants, such as knee ... 2015 Radiological Society of North America Annual Meeting ... and supports diagnostic confidence of this growing patient population. ...
Breaking Medicine Technology: